Paper38720342
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
Lin H and 5 others. J Hematol Oncol, 2024. Cited by 329 papers, by iCite.
Cite this record
ConductScience Library. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. Papers, record 38720342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38720342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Brain Neoplasms | Major topic |
| Myeloid-Derived Suppressor Cells | Major topic |
| Humans | |
| Glioma | |
| Glioblastoma | |
| Animals | |
| Immunotherapy | |
| T-Lymphocytes, Regulatory |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2020YFA0804200 | National Key Research and Development Program of China | PubMed |
Source PubMed
References810
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11905803 | Improving the efficacy of antibody-based cancer therapies. | Nat Rev Cancer | 2001 | https://conductscience.org/library/papers/11905803 | PubMed |
| 2 | 24812208 | The cellular and molecular origin of tumor-associated macrophages. | Science | 2014 | https://conductscience.org/library/papers/24812208 | PubMed |
| 3 | 26411680 | Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner. | Cell Rep | 2015 | https://conductscience.org/library/papers/26411680 | PubMed |
| 4 | 37855702 | Hypoxia-Induced Neuronal Activity in Glioma Patients Polarizes Microglia by Potentiating RNA m6A Demethylation. | Clin Cancer Res | 2024 | https://conductscience.org/library/papers/37855702 | PubMed |
| 5 | 28174424 | Targeting A2 adenosine receptors in cancer. | Immunol Cell Biol | 2017 | https://conductscience.org/library/papers/28174424 | PubMed |
| 6 | 30996346 | Fatty acid transport protein 2 reprograms neutrophils in cancer. | Nature | 2019 | https://conductscience.org/library/papers/30996346 | PubMed |
| 7 | 36823172 | Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas. | Nat Commun | 2023 | https://conductscience.org/library/papers/36823172 | PubMed |
| 8 | 35921473 | Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy. | Sci Transl Med | 2022 | https://conductscience.org/library/papers/35921473 | PubMed |
| 9 | 32103175 | Epigenetic therapy inhibits metastases by disrupting premetastatic niches. | Nature | 2020 | https://conductscience.org/library/papers/32103175 | PubMed |
| 10 | 23707073 | EGFR mutation-induced alternative splicing of Max contributes to growth of glycolytic tumors in brain cancer. | Cell Metab | 2013 | https://conductscience.org/library/papers/23707073 | PubMed |
| 11 | 28425506 | Oncogenic activity of SOX1 in glioblastoma. | Sci Rep | 2017 | https://conductscience.org/library/papers/28425506 | PubMed |
| 12 | 34836966 | Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma. | Nat Commun | 2021 | https://conductscience.org/library/papers/34836966 | PubMed |
| 13 | 33837065 | IFNγ Is Critical for CAR T Cell-Mediated Myeloid Activation and Induction of Endogenous Immunity. | Cancer Discov | 2021 | https://conductscience.org/library/papers/33837065 | PubMed |
| 14 | 26019222 | SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/26019222 | PubMed |
| 15 | 35806051 | Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806051 | PubMed |
| 16 | 35264604 | MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization. | Sci Rep | 2022 | https://conductscience.org/library/papers/35264604 | PubMed |
| 17 | 23639634 | Potential role of annexin A7 in cancers. | Clin Chim Acta | 2013 | https://conductscience.org/library/papers/23639634 | PubMed |
| 18 | 33314398 | Tumor cell and immune cell profiles in primary human glioblastoma: Impact on patient outcome. | Brain Pathol | 2021 | https://conductscience.org/library/papers/33314398 | PubMed |
| 19 | 36646788 | Nucleus-exported CLOCK acetylates PRPS to promote de novo nucleotide synthesis and liver tumour growth. | Nat Cell Biol | 2023 | https://conductscience.org/library/papers/36646788 | PubMed |
| 20 | 32760014 | Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. | Nat Rev Clin Oncol | 2020 | https://conductscience.org/library/papers/32760014 | PubMed |
Cited by271
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 329 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42983473 | Integrated single-nucleus and spatial transcriptomics define tumour cell metaprograms and tumour microenvironment organisation in choroid plexus tumours. | Genome Med | 2026 | https://conductscience.org/library/papers/42983473 | PubMed |
| 42970103 | Cytomegalovirus and cancer stem cells: a hidden alliance in tumor progression and therapy resistance. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42970103 | PubMed |
| 42909908 | Targeting NOTCH-immune crosstalk in gliomas: from mechanisms to therapeutics. | Front Oncol | 2026 | https://conductscience.org/library/papers/42909908 | PubMed |
| 42891212 | Beyond M1 M2: single-cell insights into how glioblastoma reshapes tumour-associated macrophages. | Front Immunol | 2026 | https://conductscience.org/library/papers/42891212 | PubMed |
| 42882837 | H3K27M Mutation Modulates the Antigenic Landscape in Diffuse Midline Glioma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42882837 | PubMed |
| 42852014 | Reassessing Viral Gene Therapy for Glioblastoma: Translational Opportunities and Challenges. | Yale J Biol Med | 2026 | https://conductscience.org/library/papers/42852014 | PubMed |
| 42850382 | LAIR1 suppresses phagocytosis via SHP2/USP22-mediated MYH9 degradation in glioma-associated microglia/macrophages to drive immunosuppression. | Br J Cancer | 2026 | https://conductscience.org/library/papers/42850382 | PubMed |
| 42823681 | Integrative transcriptomic and experimental analyses identifies SDF4 as an astrocyte-expressed regulator of glioma progression through PI3K-AKT signaling. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42823681 | PubMed |
| 42820111 | Targeting the Siglec/sialic-acid axis in glioblastoma: Glycome-mediated immune evasion and emerging therapeutic platforms. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42820111 | PubMed |
| 42818904 | HIST1H2BJ is associated with poor prognosis and an immune-altered tumor microenvironment in glioma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42818904 | PubMed |
| 42807322 | SH2B3 Promotes PD-L1-Mediated Immune Evasion in Glioblastoma via BRCC3-Dependent IGF2BP2 Stabilization. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42807322 | PubMed |
| 42768359 | Sprayable hydrogel loaded with engineered fusion cellular vesicles for cancer recurrence suppression. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42768359 | PubMed |
| 42746145 | The neuro-immune axis in cancer: mechanisms of neural regulation of immunity within the tumor microenvironment to promote cancer progression. | Front Immunol | 2026 | https://conductscience.org/library/papers/42746145 | PubMed |
| 42744390 | LRIG2 suppresses NK cell-induced GSDME-mediated pyroptosis via the LAMP1-STAT3 pathway in glioma. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42744390 | PubMed |
| 42737768 | Myeloid-Derived Suppressor Cells (MDSCs) in Cardiovascular Risk of Obesity-Associated Diabetes. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737768 | PubMed |
| 42732035 | Artificial intelligence-guided discovery of fungal ergosterol derivatives as selective LXRβ agonists targeting the cholesterol dependency of glioblastoma. | Mol Divers | 2026 | https://conductscience.org/library/papers/42732035 | PubMed |
| 42706275 | MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression in mice. | Nat Commun | 2026 | https://conductscience.org/library/papers/42706275 | PubMed |
| 42699756 | Local Nanomedicine and Nano-Enabled Biomaterials After Glioblastoma Resection. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42699756 | PubMed |
| 42682642 | Biomimetic PD-1-MSCs membrane-engineered nanoparticles for enhanced blood-brain barrier penetration and anti- glioma therapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42682642 | PubMed |
| 42667153 | Chemotherapy-Activated GSK3β-DNMT1 Signaling Upregulates CD47 to Evade Macrophage Phagocytosis and Drive Temozolomide Resistance in Glioblastoma. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42667153 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PTPRC | 5788 | PubTator's text mining | https://conductscience.org/library/genes/5788 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38720342
GET https://conductscience.org/api/papers/v1/38720342/references?page=2